Clinical Trial Update: Interpretation of Serological Tests in the Diagnosis of Celiac Disease: Anti-deamidated Gliadin Peptide Antibodies Revisited

View source ↗

Summary

A completed clinical trial update evaluating the interpretation of serological tests for celiac disease using anti-deamidated gliadin peptide antibodies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Snippet

Sponsor: CHU de Reims | Conditions: Celiac Disease | Status: COMPLETED